Have you read this article featuring our employee-owner AJ Singhal? AJ will be leading the Drug Discovery Group at CFD while also acting as CEO of PoP Therapeutics. As CEO of PoP Therapeutics, he aims to make more antibiotics available to the market and hopes to do so over the next several years. We thank you AJ for all of your hard work and CFD is honored to have you represent our company!
Meet the individuals behind the incredible technology and innovation in #CRPHSV with CRPeople! Learn more about interesting perspectives through the unique companies in The Park starting with AJ Singhal, Group Leader of the Drug Discovery Group at CFD Research Corporation. Read more about AJ Singhal and CRPeople: https://lnkd.in/eNnEj3E6